期刊
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
卷 50, 期 4, 页码 1636-1643出版社
ASSOC RESEARCH VISION OPHTHALMOLOGY INC
DOI: 10.1167/iovs.08-1882
关键词
-
资金
- Dairy Australia
PURPOSE. The purpose of this study was to investigate the effect of bovine lactoferrin (BLF) on human corneal epithelial wound healing using an in vitro alkali-induced wound model and to understand its role in promoting wound healing. METHODS. Confluent human corneal limbal epithelial (HCLE) cells wounded using 0.5 mu L of 0.1 M sodium hydroxide were treated with BLF (0, 0.1, 1, 2.5, and 5 mg/mL) or anti-human interleukin- 6 (IL-6) receptor neutralizing antibody (anti-IL-6 antibody; 1, 10, and 50 mu g/mL) or tyrphostin AG1295 (an inhibitor of platelet-derived growth factor [PDGF] receptor kinase; 1 and 10 mu M), IL-6, or PDGF- BB. The conditioned medium collected for BLF treatment (0 and 5 mg/mL) was analyzed using a protein array for a number of cytokines/growth factors involved in corneal wound healing. A preliminary animal study using mice was carried out to determine the effect of BLF on alkali wounds. RESULTS. BLF at 2.5 and 5 mg/mL promoted wound healing (P < 0.01). During wound closure, BLF upregulated PDGF- BB 180-fold and IL-6 10-fold compared with control. Treatment with tyrphostin AG1295 (10 mu M; P < 0.01) or anti-IL-6 antibody (50 mu g/mL; P < 0.01) in the presence of BLF inhibited wound closure, whereas the addition of exogenous IL-6 and PDGF- BB promoted wound closure. Preliminary animal studies have shown that LF (5 mg/mL) promotes alkali wound healing in vivo. CONCLUSIONS. These results suggest that BLF at >= 2.5 mg/mL stimulates HCLE wound healing, and this stimulation is mediated through the upregulation of PDGF or IL-6. (Invest Ophthalmol Vis Sci. 2009; 50: 1636-1643) DOI:10.1167/iovs.081882
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据